The Latest Breaking News from PBMs

Walk into your local pharmacy, and you may find the same story repeated: the medication you rely on is “out of stock.” For seniors managing...

Cuban’s Cost Plus Drugs, which he founded in 2022, similarly provides direct-to-consumer discounted pharmaceuticals.

FTC report exposes PBMs inflating drug prices, sparking debate on industry oversight.

GOP spending bill proposal excludes reforms for pharmacy benefit managers (PBMs) despite bipartisan expectations.

Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity, heart disease and other chronic conditions that afflict millions of Americans. But while everyone agrees these drugs have the potential to transform lives, no one can agree on how best to pay for them.

Kentucky’s attorney general has expanded an opioid-related lawsuit to target another pharmacy benefit manager

Congress and President Joe Biden can address the problem of PBMs -- Pharmacy Benefit Managers -- by passing two bipartisan reforms during the current "lame duck" legislative session.

Novo Nordisk is investing $30 billion to expand production, but middlemen are pocketing 74 cents of every dollar it makes in sales.

FTC lawsuit targets major PBMs for inflating insulin prices, impacting patients and drug costs. Debate over drug pricing and PBM role in healthcare system ...